2026 ICD-10-CM Diagnosis Code T45.515AAdverse effect of anticoagulants, initial encounter

ICD-10-CM CodesS00–T88T36-T50T45

ICD-10-CM T45.515A
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

T45.515A is a billable ICD-10-CM diagnosis code for adverse effect of anticoagulants, initial encounter. The 7th character A marks it as an initial encounter code, used while the patient is receiving active treatment. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 917 through 918. The code is not accepted as a principal diagnosis by the Medicare Code Editor. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Adverse effects of drugs and medicaments, initial encounter.

Code Identity

ICD-10-CM Code
T45.515A
Billable Status
Yes — Valid for Submission
Code Describes
Adverse effect of anticoagulants, initial encounter
Short Description
Adverse effect of anticoagulants, initial encounter
Same as the full description in the CMS dataset.
Parent Code
Adverse effect of anticoagulants

Code Classification

ChapterS00–T88Injury, poisoning and certain other consequences of external causes
SectionT36-T50Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
CategoryT45Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified
This CodeT45.515AAdverse effect of anticoagulants, initial encounter

Code EditsBilling

Medicare Code Editor checks that affect claim validity for T45.515A.

There are selected codes that describe a circumstance which influences an individual's health status but not a current illness or injury, or codes that are not specific manifestations but may be due to an underlying cause. These codes are considered unacceptable as a principal diagnosis.

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Acenocoumarol adverse reaction
  • Adverse reaction to coumarin
  • Adverse reaction to danaparoid
  • Adverse reaction to indanedione
  • Anticoagulant adverse reaction
  • Coumarin necrosis
  • Dalteparin adverse reaction
  • Dermatosis caused by coumarin
  • Dermatosis resulting from anticoagulant therapy
  • Direct acting anticoagulant adverse reaction
  • Enoxaparin adverse reaction
  • Heparin adverse reaction
  • Heparinoid adverse reaction
  • Indirect acting anticoagulant adverse reaction
  • Pesticide adverse reaction
  • Phenindione adverse reaction
  • Rectal hemorrhage caused by apixaban
  • Rectal hemorrhage caused by drug
  • Tinzaparin adverse reaction
  • Transfusion reaction caused by toxic effect of anticoagulant
  • Warfarin adverse reaction
  • Warfarin monitoring status
  • Warfarin side effects

Coding GuidelinesGuidance

When coding an adverse effect of a drug that has been correctly prescribed and properly administered, assign the appropriate code for the nature of the adverse effect followed by the appropriate code for the adverse effect of the drug.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified (T45). Use the following options for the applicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2026, published by CMS and the National Center for Health Statistics.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR INJ028
Adverse effects of drugs and medicaments, initial encounter
Default principal diagnosis: inpatient No · outpatient Yes

Clinical InformationClinical

  • Acenocoumarol

    a coumarin that is used as an anticoagulant. its actions and uses are similar to those of warfarin. (from martindale, the extra pharmacopoeia, 30th ed, p233)
  • Phenindione

    an indandione that has been used as an anticoagulant. phenindione has actions similar to warfarin, but it is now rarely employed because of its higher incidence of severe adverse effects. (from martindale, the extra pharmacopoeia, 30th ed, p234)
  • Phenprocoumon

    coumarin derivative that acts as a long acting oral anticoagulant.
  • Warfarin

    an anticoagulant that acts by inhibiting the synthesis of vitamin k-dependent coagulation factors. warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. it is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. warfarin is also used as a rodenticide.

Table of Drugs and ChemicalsClinical

Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.

SubstanceAccidentalSelf-harmAssaultUndeter­minedAdverse
Effect
Under­dosing
AcenocoumarinT45.511T45.512T45.513T45.514T45.515T45.516
AcenocoumarolT45.511T45.512T45.513T45.514T45.515T45.516
AnisindioneT45.511T45.512T45.513T45.514T45.515T45.516
Anticoagulant NECT45.511T45.512T45.513T45.514T45.515T45.516
Anticoagulant NEC::AntagonistT45.511T45.512T45.513T45.514T45.515T45.516
BishydroxycoumarinT45.511T45.512T45.513T45.514T45.515T45.516
BromindioneT45.511T45.512T45.513T45.514T45.515T45.516
CoumadinT45.511T45.512T45.513T45.514T45.515T45.516
Coumadin::rodenticideT45.511T45.512T45.513T45.514T45.515T45.516
CoumarinT45.511T45.512T45.513T45.514T45.515T45.516
CoumetarolT45.511T45.512T45.513T45.514T45.515T45.516
CumetharolT45.511T45.512T45.513T45.514T45.515T45.516
DaniloneT45.511T45.512T45.513T45.514T45.515T45.516
Dicoumarol, dicoumarin, dicumarolT45.511T45.512T45.513T45.514T45.515T45.516
DiphenadioneT45.511T45.512T45.513T45.514T45.515T45.516
Diphenadione::rodenticideT45.511T45.512T45.513T45.514T45.515T45.516
Drotrecogin alfaT45.511T45.512T45.513T45.514T45.515T45.516
Enoxaparin (sodium)T45.511T45.512T45.513T45.514T45.515T45.516
FluindioneT45.511T45.512T45.513T45.514T45.515T45.516
Heparin (sodium)T45.511T45.512T45.513T45.514T45.515T45.516
Heparin (sodium)::action reverserT45.511T45.512T45.513T45.514T45.515T45.516
Heparin-fractionT45.511T45.512T45.513T45.514T45.515T45.516
Heparinoid (systemic)T45.511T45.512T45.513T45.514T45.515T45.516
Indandione (derivatives)T45.511T45.512T45.513T45.514T45.515T45.516
Indendione (derivatives)T45.511T45.512T45.513T45.514T45.515T45.516
NicoumaloneT45.511T45.512T45.513T45.514T45.515T45.516
PanwarfinT45.511T45.512T45.513T45.514T45.515T45.516
PhenindioneT45.511T45.512T45.513T45.514T45.515T45.516
PhenprocoumonT45.511T45.512T45.513T45.514T45.515T45.516
SintromT45.511T45.512T45.513T45.514T45.515T45.516
TioclomarolT45.511T45.512T45.513T45.514T45.515T45.516
WarfarinT45.511T45.512T45.513T45.514T45.515T45.516
Warfarin::rodenticideT45.511T45.512T45.513T45.514T45.515T45.516
Warfarin::sodiumT45.511T45.512T45.513T45.514T45.515T45.516
XigrisT45.511T45.512T45.513T45.514T45.515T45.516
ZovantT45.511T45.512T45.513T45.514T45.515T45.516

Patient EducationClinical

Drug Reactions

Most of the time, medicines make our lives better. They reduce aches and pains, fight infections, and control problems such as high blood pressure or diabetes. But medicines can also cause unwanted reactions, such as drug interactions, side effects, and allergies.

The full article covers:

  • What is a drug interaction?
  • What are side effects?
  • What are drug allergies?
  • How can I stay safe when taking medicines?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert T45.515A to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
995.29 Adv eff med/biol NEC/NOS
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.
ICD-9-CM
E934.2 Adv eff anticoagulants
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About T45.515AOverview

Is T45.515A (Adverse effect of anticoagulants) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report adverse effect of anticoagulants, initial encounter on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What does the 7th character A in T45.515A mean?

The final character A marks the initial encounter: use it while the patient is receiving active treatment for adverse effect of anticoagulants, such as an emergency visit or first evaluation.

What MS-DRG does T45.515A group to?

On inpatient claims, adverse effect of anticoagulants, initial encounter maps to MS-DRG 917, 918, with relative weights from 0.8571 to 1.5684 depending on complications. Higher weights mean higher Medicare reimbursement.

Can T45.515A be a principal diagnosis?

No. The Medicare Code Editor rejects this code as a principal diagnosis because adverse effect of anticoagulants, initial encounter describes a circumstance that influences health status rather than a current illness. Report it as a secondary diagnosis.

What is the ICD-9 equivalent of T45.515A?

Under the General Equivalence Mappings, adverse effect of anticoagulants, initial encounter converts to ICD-9-CM 995.29 (adv eff med/biol NEC/NOS) and E934.2 (adv eff anticoagulants). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.